Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Aratana Therapeutics, Inc. (PETX)

« Back to company index

PETX Chatter Timeline

Stock Ticker for PETX

Most Active Tweeters for PETX

UserTweets
@Tickeron 6

Recent Tweets for PETX

Tickeron @Tickeron
$PETX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/1IZ5pYY8xs
September 14th 2019, 6:09am
Tickeron @Tickeron
$PETX's 10-day Moving Average broke below its 50-day Moving Average on July 29, 2019. View odds for this and other… https://t.co/ABTYkRQjCf
September 13th 2019, 3:09am
Tickeron @Tickeron
$PETX's price moved below its 50-day Moving Average on July 24, 2019. View odds for this and other indicators:… https://t.co/sfQZcAhLHp
September 12th 2019, 4:09am
Tickeron @Tickeron
$PETX in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on June 25, 2019. View odds f… https://t.co/Q4wUVtdLw9
September 11th 2019, 4:09am
Tickeron @Tickeron
$PETX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/g1oM6BEtfV
September 10th 2019, 4:09am
Tickeron @Tickeron
$PETX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/wRQiNVwes6
September 9th 2019, 2:09am
Tickeron @Tickeron
$PETX enters an Uptrend as Momentum Indicator exceeded the 0 level on July 31, 2019. View odds for this and other i… https://t.co/oN2bf693fR
August 11th 2019, 3:08am
dailypoliticaln @dailypoliticaln
Brokerages Set Aratana Therapeutics Inc $PETX Target Price at $4.73 https://t.co/CYS2A6C0eW
August 10th 2019, 10:08pm
WatchlistN @WatchlistN
Brokerages Set Aratana Therapeutics Inc $PETX Target Price at $4.73 https://t.co/bnKDxNDmJk
August 10th 2019, 10:08pm
Tickeron @Tickeron
$PETX in Uptrend: 50-day Moving Average moved above 200-day Moving Average on August 7, 2019. View odds for this an… https://t.co/RoYWGx6jY3
August 10th 2019, 3:08am
Tickeron @Tickeron
$PETX in Uptrend: 50-day Moving Average moved above 200-day Moving Average on August 7, 2019. View odds for this an… https://t.co/gYxQV5EsBR
August 9th 2019, 2:08am
ConsumerFeed @ConsumerFeed
Aratana Therapeutics Inc $PETX Receives Average Rating of “Hold” from Brokerages https://t.co/gP3JCOf6SV
August 8th 2019, 7:08pm
Tickeron @Tickeron
$PETX enters an Uptrend as Momentum Indicator exceeded the 0 level on July 31, 2019. View odds for this and other i… https://t.co/pVnguEUt9M
August 8th 2019, 4:08am
Tickeron @Tickeron
$PETX enters an Uptrend as Momentum Indicator exceeded the 0 level on July 31, 2019. View odds for this and other i… https://t.co/d67WJfbalS
August 7th 2019, 4:08am
Tickeron @Tickeron
$PETX enters an Uptrend because Momentum Indicator exceeded the 0 level on July 31, 2019. View odds for this and ot… https://t.co/3VzWXEVHQF
August 6th 2019, 2:08am
ChartMill @ChartMill
$PETX: The EPS has grown by an impressive 68.24% over the past year. https://t.co/M0yvCyohfc https://t.co/bJS7ZXjCKs
August 5th 2019, 7:08am
AmericanBanking @AmericanBanking
Aratana Therapeutics Inc $PETX Receives Average Rating of “Hold” from Analysts https://t.co/V34Z9gTW0E #stocks
August 3rd 2019, 1:08pm
bbnsnews @bbnsnews
Aratana Therapeutics Inc $PETX Receives Consensus Rating of “Hold” from Analysts https://t.co/OQrR5gbx30
August 3rd 2019, 1:08pm
Tickeron @Tickeron
$PETX enters an Uptrend because Momentum Indicator exceeded the 0 level on July 31, 2019. View odds for this and ot… https://t.co/EWlZzbLLrz
August 3rd 2019, 7:08am
Tickeron @Tickeron
$PETX enters an Uptrend because Momentum Indicator exceeded the 0 level on July 31, 2019. View odds for this and ot… https://t.co/w1a5XIEZCu
August 2nd 2019, 7:08am
Tickeron @Tickeron
$PETX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/ptk8w0d5uP
August 1st 2019, 5:08am
Tickeron @Tickeron
$PETX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/kc9ygSIr92
July 30th 2019, 5:07am
fintel_io @fintel_io
Integrated Core Strategies (us) Llc has filed a new 13G, reporting 0.0% ownership in $PETX - https://t.co/jdunK9Ebli
July 29th 2019, 5:07pm
EvrPink @EvrPink
instock58: $PETX Running..up 115% https://t.co/GBPSkYgVH7
July 29th 2019, 3:07pm
Tickeron @Tickeron
$PETX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/bfAL9SwPQ0
July 29th 2019, 5:07am
Tickeron @Tickeron
$PETX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/BCkYlXpYbI
July 28th 2019, 6:07am
Tickeron @Tickeron
$PETX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/D7ZoOzf8vQ
July 27th 2019, 7:07am
SchmuzieZuck @SchmuzieZuck
$PETX I had to take it off another of my watchlists. It still hurts. But I also leave dead people on my contacts li… https://t.co/IB7E0c5evx
July 26th 2019, 9:07am
Tickeron @Tickeron
$PETX in Downtrend: 50-day Moving Average broke below 200-day Moving Average on February 12, 2019. View odds for th… https://t.co/3Cai41YeuM
July 26th 2019, 5:07am
confcalltran @confcalltran
Major owner of Aratana Therapeutics just disposed of 7,258,135 shares https://t.co/L9VBLznh2p $PETX
July 22nd 2019, 4:07pm
FlashAlert_me @FlashAlert_me
$PETX filed SEC form 4: 10% Owner Broadfin Healthcare Master Fund Ltd: Sold 7258135 of Common Stock at price on 2… https://t.co/1XEhfSjjFV
July 22nd 2019, 4:07pm
confcalltran @confcalltran
Kevin Kotler just issued a filing suggesting it has sold all of its Aratana Therapeutics https://t.co/KSj4oL2Yag $PETX
July 22nd 2019, 4:07pm
fintel_io @fintel_io
Broadfin Capital, LLC has closed their entire position in $PETX - https://t.co/jdunK9mAtK
July 22nd 2019, 4:07pm
FlashAlert_me @FlashAlert_me
$PETX filed form SC 13G/A on July 22, 16:08:45 https://t.co/1WB0jB960u
July 22nd 2019, 4:07pm
confcalltran @confcalltran
Aratana Therapeutics Just Received a Notice of Effectiveness https://t.co/CHIcs9SwfQ $PETX
July 22nd 2019, 6:07am
confcalltran @confcalltran
Aratana Therapeutics Just Received a Notice of Effectiveness https://t.co/L37eYcNoQn $PETX
July 22nd 2019, 6:07am
FlashAlert_me @FlashAlert_me
$PETX filed form EFFECT on July 22, 00:15:19 https://t.co/bDmulycGJW
July 22nd 2019, 6:07am
FlashAlert_me @FlashAlert_me
$PETX filed form EFFECT on July 22, 00:15:19 https://t.co/JJIq6lM1cA
July 22nd 2019, 6:07am
lukerehmann @lukerehmann
Aratana Therapeutics $PETX performed a stock merger. Shareholders will receive 0.1481 shares of ELAN for each share… https://t.co/RcDtE47Iuf
July 19th 2019, 12:07pm
InsiderAlertsIA @InsiderAlertsIA
$PETX: New Insider Filing on SEE REMARKS JOHN C AYRES: https://t.co/uPpmA7MjzK
July 18th 2019, 8:07pm
FlashAlert_me @FlashAlert_me
$PETX filed SEC form 4: Director YARNO WENDY L: Sold 18000 of Common Stock at price on 2019-07-18. https://t.co/MsgUwqOl3O
July 18th 2019, 7:07pm
FlashAlert_me @FlashAlert_me
$PETX filed SEC form 4: Director Vander Vort John: Sold 43000 of Common Stock at price on 2019-07-18. https://t.co/DJZgFprZHQ
July 18th 2019, 7:07pm
FlashAlert_me @FlashAlert_me
$PETX filed SEC form 4: President and CEO TOOMAN CRAIG A: Sold 307501 of Common Stock at price on 2019-07-18. https://t.co/HF2sdoP4Lk
July 18th 2019, 7:07pm
FlashAlert_me @FlashAlert_me
$PETX filed SEC form 4: Director ROCHE ROBERT P JR: Sold 18000 of Common Stock at price on 2019-07-18. https://t.co/mjKUUUZ2je
July 18th 2019, 7:07pm
FlashAlert_me @FlashAlert_me
$PETX filed SEC form 4: Director ROBINSON LOWELL W: Sold 4500 of Common Stock at price on 2019-07-18. https://t.co/rgwVe76M5X
July 18th 2019, 7:07pm
FlashAlert_me @FlashAlert_me
$PETX filed SEC form 4: VP of Sales and Marketing READY CHRISTOPHER T: Sold 53728 of Common Stock at price on 201… https://t.co/LYleZtUzIC
July 18th 2019, 7:07pm
FlashAlert_me @FlashAlert_me
$PETX filed SEC form 4: Director RAINES MERILEE: Sold 18000 of Common Stock at price on 2019-07-18. https://t.co/gzHHQdQkbe
July 18th 2019, 7:07pm
FlashAlert_me @FlashAlert_me
$PETX filed SEC form 4: Director Hockaday Irvine O Jr: Sold 82985 of Common Stock at price on 2019-07-18. https://t.co/wzllOCV1CA
July 18th 2019, 7:07pm
FlashAlert_me @FlashAlert_me
$PETX filed SEC form 4: CHIEF FINANCIAL OFFICER HELLUMS RHONDA LYNETTE: Sold 51424 of Common Stock at price on 20… https://t.co/0rZdcg1HKO
July 18th 2019, 7:07pm
FlashAlert_me @FlashAlert_me
$PETX filed SEC form 4: Chief Development Officer HEINEN ERNST: Sold 170617 of Common Stock at price on 2019-07-1… https://t.co/GEvD675qma
July 18th 2019, 7:07pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.